Fulgent Genetics, Inc. (FLGT) › Cash & EquivalentsFulgent Genetics, Inc. (FLGT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2015: $489.0K2016: $7.90M2017: $6.49M2018: $6.74M2019: $11.96M2020: $87.43M2021: $164.89M2022: $79.51M2023: $97.47M2024: $55.14M2025: $50.19M$50.19M2015Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$50.19M-9.0%2024$55.14M-43.4%2023$97.47M+22.6%2022$79.51M-51.8%2021$164.89M+88.6%2020$87.43M+630.7%2019$11.96M+77.6%2018$6.74M+3.8%2017$6.49M-17.8%2016$7.90M+1514.9%2015$489.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share